IP Library Granted Patent US 7,025,063
Granted Patent B2
US 7,025,063 · App. 09/939,098 · Granted Apr 11, 2006

Coated sling material

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,025,063
App. No.
09/939,098
Granted
Apr 11, 2006
Kind
B2
Abstract

The present invention relates to a sling, methods of making and using a sling, and kits comprising a sling for treating urinary incontinence. The sling has multiple elongation properties that serve to improve the support of the urethra. The sling may comprise a coated material adapted for urethral suspension. The coated sling has properties that appear to enhance the sling elongation characteristics. The coated sling further includes properties that reduce its susceptibility to bacterial infections. The sling further includes properties to enhance the proper tensioning of the sling.

Claims (71)

1. A sling for insertion into a patient comprising:

a surgical sling adapted to support the urethra in its normal anatomic position and to prevent abnormal urethral descent under intraabdominal pressure;

said surgical sling comprising a length of material having a longitudinal axis, and a latitudinal axis;

wherein said material has a first elongation property along said longitudinal axis, and a second elongation property along said latitudinal axis,

said first and second elongation property being different from each other, and

wherein said second elongation property is greater than said first elongation property.

2. A sling for insertion into a patient comprising;

a surgical sting adapted to support the urethra in its normal anatomic position and to prevent abnormal urethral descent under intraabdominal pressure;

said surgical sling comprising a length of material having a longitudinal axis, and a latitudinal axis;

wherein said material has a first elongation property along said longitudinal axis, and a second elongation property along said latitudinal axis,

said first and second elongation property being different from each other, and

wherein said first elongation property is approximately 8% elongation beyond a normal state of said sling material when said sling material is subjected to a tension of approximately 5 lbs.

3. The sling as set forth in claim 2 , wherein said second elongation property is approximately 36% elongation beyond a normal state of said sling material when said sling material is subjected to a tension of approximately 5 lbs.

4. A sling for insertion into a patient comprising:

a surgical sling adapted to support the urethra in its normal anatomic position and to prevent abnormal urethral descent under intraabdominal pressure;

said surgical sling comprising a length of material having a longitudinal axis, and a latitudinal axis;

wherein said material has a first elongation property along said longitudinal axis, and a second elongation property along said latitudinal axis,

said first and second elongation property being different from each other, and

wherein said first elongation property is in the range of approximately 24%-28% elongation beyond a normal state of said sling material when said sling is subjected to a tension of approximately 20 lbs.

5. The sling as set forth in claim 4 wherein said second elongation property is in the range of approximately 65%-75% elongation beyond a normal state of said sling material when said sling is subjected to a tension of approximately 20 lbs.

6. A sling for insertion into a patient comprising:

a surgical sling adapted to be implanted in a tension free rest position to support the urethra;

said surgical sling material comprising a length of polypropylene material having pores for promoting tissue ingrowth, a pair of major surface, a pair of ends and a pair of edges, and a longitudinal axis;

wherein said polypropylene material has a central region with at least one major surface coated with silicone, the silicone coated central region being adapted to be placed adjacent the urethra to avoid tissue erosion, and end regions without silicone coating; and

wherein said silicone coated polypropylene in the central region has a thickness within the range of approximately 0.024″ (0.61 mm) to 0.036″ (0.914 mm).

7. A sling for insertion into a patient comprising:

a surgical sling adapted to support the urethra in its normal anatomic position and to prevent abnormal urethral descent under intraabdominal pressure;

said surgical sling comprising a length of material having a longitudinal axis, and a latitudinal axis;

wherein said material has a first elongation property along said longitudinal axis, and a second elongation property along said latitudinal axis,

said first and second elongation property being different from each other,

said material is coated with a substance that enhances biocompatibility, and

wherein said first elongation property is in the range of approximately 19.5-21.5% elongation beyond a normal state of said sling material when said sling material is subject to a tension of approximately 20 lbs.

8. The sling as set forth in claim 7 wherein said second elongation property is in the range of approximately 120-130% elongation beyond a normal state of said sling material when said sling material is subject to a tension of approximately 20 lbs.

9. A sling for insertion into a patient comprising:

a surgical sling adapted to support the urethra in its normal anatomic position and to prevent abnormal urethral descent under intraabdominal pressure;

said surgical sling comprising a length of material having a longitudinal axis, and a latitudinal axis;

wherein said material has a first elongation property along said longitudinal axis, and a second elongation property along said latitudinal axis,

said first and second elongation property being different from each other,

said material is coated with a substance that enhances biocompatibility, and

wherein said first elongation property is approximately 2.5% elongation beyond a normal state of said sling material when said sling material is subject to a tension of approximately 5 lbs.

10. A sling for insertion into a patient comprising:

a surgical sling adapted to support the urethra in its normal anatomic position and to prevent abnormal urethral descent under intraabdominal pressure;

said surgical sling comprising a length of material having a longitudinal axis, and a latitudinal axis;

wherein said material has a first elongation property along said longitudinal axis, and a second elongation property along said latitudinal axis,

said first and second elongation property being different from each other,

said material is coated with a substance that enhances biocompatibility, and

wherein said second elongation property is approximately 65% elongation beyond a normal state of said sling material when said sling material is subject to a tension of approximately 5 lbs.

11. A sling for insertion into a patient comprising:

a surgical sling adapted to support the urethra in its normal anatomic position and to prevent abnormal urethral descent under intraabdominal pressure;

said surgical sling comprising a length of material having a longitudinal axis, and a latitudinal axis,

wherein said material has a first elongation property along said longitudinal axis, and a second elongation property along said latitudinal axis,

said first and second elongation property being different from each other,

said material is coated with a substance that enhances biocompatibility, and

wherein said first elongation property is approximately 10.5% elongation beyond a normal state of said sling material when said sling material is subject to a tension of approximately 5 lbs.

12. A sling for insertion into a patient comprising:

a surgical sling adapted to support the urethra in its normal anatomic position and to prevent abnormal urethral descent under intraabdominal pressure;

said surgical sling comprising a length of material having a longitudinal axis, and a latitudinal axis;

wherein said material has a tint elongation property along said longitudinal axis, and a second elongation property along said latitudinal axis,

said first and second elongation property being different from each other,

said material is coated with a substance that enhances biocompatibility; and

wherein said second elongation property is approximately 25% elongation beyond a normal state of said sling material when said sling material is subject to a tension of approximately 5 lbs.

13. A sling for insertion into a patient comprising:

a surgical sling adapted to support the urethra in its normal anatomic position and to prevent abnormal urethral descent under intraabdominal pressure;

said surgical sling comprising a length of material having a longitudinal axis, and a latitudinal axis;

wherein said sling comprises a plurality of regions along its longitudinal axis and wherein each region contain differing elongation properties from an immediately adjacent region, and

wherein said sling material has a coated central region having an increased longitudinal elongation property and a somewhat decreased latitudinal elongation property as compared to elongation properties of said central region in a normal state.

14. A sling as set forth in claim 13 , wherein said sling material has a coated intermediate region on either side of said central region, each of said intermediate regions having a decreased longitudinal elongation property and an increased latitudinal elongation property as compared to elongation properties of each of said intermediate regions in a normal state.

15. A sling as set forth in claim 14 , wherein said sling material has a coated end region adjacent each intermediate region, each of said end regions having a decreased longitudinal elongation property and an increased latitudinal elongation property as compared to elongation properties of each of said end regions in a normal state.

16. A sling according to claim 6 wherein the pores of the polypropylene material in the central region remain open and clear of silicone.

17. A sling according to claim 6 wherein said polypropylene comprises non-knitted polypropylene fibers.

18. A sling according to claim 17 wherein said non-knitted polypropylene fibers are multidirectional.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2016
From: AMERICAN MEDICAL SYSTEMS, LLC
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 037901/0883 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2016
From: AMS RESEARCH, LLC
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 037901/0941 →
RELEASE OF SECURITY INTEREST Recorded Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
RELEASE OF PATENT SECURITY INTEREST Recorded Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: AMS RESEARCH CORPORATION
Reel/Frame 032380/0053 →
SECURITY AGREEMENT Recorded Jul 22, 2011
From: AMS RESEARCH CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026632/0535 →